Literature DB >> 8941229

Dermatologic complications of HIV infection.

P L Myskowski1, R Ahkami.   

Abstract

Cutaneous disorders occur with great frequency in patients with HIV infection and increase in number and severity as the disease progresses and immune function declines. In addition, the first findings related to HIV infection are often on the skin. Cutaneous infections with herpesviruses may be severe and atypical in their presentations; papillomaviruses and MC are common as well. Bacterial infections may be primary or secondary to other skin diseases; superficial and deep fungal infections are also prevalent. Papulosquamous disorders, including seborrheic dermatitis, psoriasis, and eczema, may be disfiguring and result in secondary complications. Neoplastic disorders, especially Kaposi's sarcoma, demand early diagnosis, to afford the patient maximal treatment options. All physicians must be aware of these cutaneous manifestations to decrease morbidity and improve quality of life in the HIV-infected individual.

Entities:  

Mesh:

Year:  1996        PMID: 8941229     DOI: 10.1016/s0025-7125(05)70496-x

Source DB:  PubMed          Journal:  Med Clin North Am        ISSN: 0025-7125            Impact factor:   5.456


  3 in total

1.  The frequency of CLA+ CD8+ T cells in the blood of psoriasis patients correlates closely with the severity of their disease.

Authors:  H Sigmundsdóttir; J E Gudjónsson; I Jónsdóttir; B R Lúdvíksson; H Valdimarsson
Journal:  Clin Exp Immunol       Date:  2001-11       Impact factor: 4.330

Review 2.  Immunopathogenic mechanisms in psoriasis.

Authors:  J E Gudjonsson; A Johnston; H Sigmundsdottir; H Valdimarsson
Journal:  Clin Exp Immunol       Date:  2004-01       Impact factor: 4.330

3.  The pattern of mucocutaneous disorders in HIV-infected children attending care and treatment centres in Dar es Salaam, Tanzania.

Authors:  Millembe F Panya; Yassin M Mgonda; Augustine W Massawe
Journal:  BMC Public Health       Date:  2009-07-14       Impact factor: 3.295

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.